Browse EyeWorld Weekly ophthalmology news on EyeWorld.org. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Study: ocular manifestations of Mpox
➤ ‘World’s first’ spiral IOL designed with artificial intelligence
➤ First-in-human implantation of wireless IOP sensor
➤ Final patient visit for Phase 2 wet AMD treatment trial
➤ Enrollment, dosing complete for Phase 1 AMD, DME therapy
➤ ASCRS news and events
➤ Rare Pediatric Disease designations granted for gene therapies
➤ Tentative FDA approval granted to generic drop for eye redness
➤ Acquisition news
➤ ASCRS news and events
➤ NDA submitted for presbyopia treatment
➤ FDA approves AMD treatment
➤ Primary endpoint achieved in Phase 3 trial of reproxalap for dry eye
➤ Clinical trial results that supported new excimer laser approval published
➤ Company updates on several clinical trials
➤ First patient dosed in Phase 2 trial for intravitreal steroid implant for DME treatment
➤ ASCRS news and events
➤ FDA approves expanded access for retinitis pigmentosa gene therapy
➤ Generic steroid receives FDA approval for inflammation
➤ AI-powered smart glasses provide visual help to patients with AMD
➤ ASCRS news and events
➤ FDA 510(k) clearance granted to cataract surgery system
➤ Laser for POAG receives CE Mark
➤ Collaboration to develop dry eye treatment
➤ First patients enrolled in Phase 3 wet AMD trial
➤ New open-access textbook on lens power calculations
➤ ASCRS news and events
➤ Study: protein patterns in tears predict postop pain
➤ Tentative approval for generic glaucoma drug
➤ Nanodrug recovers optic nerve in glaucoma animal model
➤ Acquisition news
➤ ASCRS news and events
ASCRS EyeWorld Weekly: View the current issue
➤ Claes Dohlman, MD, PhD, dies at 101 years old
➤ Trial to evaluate neuropathic corneal pain drug
➤ FDA clears new OCT technology
➤ Study: supplements slow progression of late-stage dry AMD
➤ Young eye surgeon scholarship opportunity
➤ Acquisition news
➤ ASCRS news and events
➤ FDA grants De Novo classification to ocular pressure adjusting pump
➤ Inaugural ‘State of Dry Eye’ survey
➤ Study: potentially higher risk for blinding ocular condition with semaglutide use
➤ Wet AMD treatment implant reintroduced
➤ Acquisition news
➤ ASCRS news and events
➤ Prospective trial reveals impact of home OCT in wet AMD management
➤ Devices receive FDA 510(k) clearance
➤ Review date set for BLA for treatment of macular telangiectasia type 2
➤ FDA grants IND to gene therapy for patients with geographic atrophy
➤ Acquisition news
➤ ASCRS news and events
➤ Allogenic cell therapy receives FDA designations
➤ Robot delivers new treatment for wet AMD
➤ Health-related quality of life measure proposed for MIGS
➤ Company meets with FDA for pediatric myopia drug candidate
➤ ASCRS news and events